Peptide radio receptor therapy: The huff and puff strategy of neuroendocrine disease management. (August 2021)

• Record Type: Journal Article
• Authors: Bodei, Lisa; Kidd, Mark; Modlin, Irvin
• Is Part Of: Current opinion in endocrine and metabolic research. Volume 19(2021)
• Page Start: 52
• Page End: 60
• Publication Date: 2021-08
• Subjects: PRRT -- Stratification -- Efficacy -- Toxicity -- Liquid biopsy; Endocrine glands -- Diseases -- Periodicals; Metabolism -- Disorders -- Periodicals; Endocrine System Diseases; Metabolic Diseases; Endocrine glands -- Diseases; Metabolism -- Disorders; Periodical; Electronic journals; Periodicals; Electronic journals; 616.4
• DOI: 10.1016/j.coemr.2021.06.002
• Languages: English
• ISSNs: 2451-9650

Abstract

Abstract: The recent development of peptide receptor radionuclide therapy (PRRT) into an accepted treatment allows for consideration of the requirements to move beyond the mere concept of tumor therapy. This chapter addresses the limitations of the "huff and puff" theory of tumor destruction by critically applying the knowledge of radionuclide therapy.